| Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey MD Tanriover, HL Doğanay, M Akova, HR Güner, A Azap, S Akhan, ... The Lancet 398 (10296), 213-222, 2021 | 953 | 2021 |
| Prevalence of nosocomial infections at intensive care units in Turkey: a multicentre 1-day point prevalence study S Esen, H Leblebicioglu, Study Group Scandinavian journal of infectious diseases 36 (2), 144-148, 2004 | 272 | 2004 |
| Tularemia in Bursa, Turkey: 205 cases in ten years S Helvacı, S Gedikoğlu, H Akalın, HB Oral European Journal of Epidemiology 16, 271-276, 2000 | 272 | 2000 |
| Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community … Y Heper, EH Akalın, R Mıstık, S Akgöz, O Töre, G Göral, B Oral, F Budak, ... European Journal of Clinical Microbiology and Infectious Diseases 25, 481-491, 2006 | 183 | 2006 |
| Clinical importance of extended-spectrum β-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains H Vahaboglu, F Coskunkan, O Tansel, R Ozturk, N Sahin, I Koksal, ... Journal of medical microbiology 50 (7), 642-645, 2001 | 176 | 2001 |
| Re-emergence of tularemia in Turkey H Akalın, S Helvacı, S Gedikoğlu International Journal of Infectious Diseases 13 (5), 547-551, 2009 | 165 | 2009 |
| A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey G Usluer, I Ozgunes, H Leblebicioglu, ... Annals of clinical Microbiology and Antimicrobials 4, 1-5, 2005 | 154 | 2005 |
| Epidemiology of sepsis in intensive care units in Turkey: a multicenter, point-prevalence study N Baykara, H Akalın, MK Arslantaş, V Hancı, Ç Çağlayan, F Kahveci, ... Critical Care 22, 1-14, 2018 | 152 | 2018 |
| Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis HB Oral, F Budak, EK Uzaslan, B Baştürk, A Bekar, H Akalın, E Ege, ... Cytokine 35 (3-4), 143-147, 2006 | 150 | 2006 |
| Acute invasive fungal rhinosinusitis: evaluation of 26 patients treated with endonasal or open surgical procedures F Kasapoglu, H Coskun, OA Ozmen, H Akalin, B Ener Otolaryngology—Head and Neck Surgery 143 (5), 614-620, 2010 | 137 | 2010 |
| Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes V Ozkocaman, T Ozcelik, R Ali, F Ozkalemkas, A Ozkan, C Ozakin, ... Journal of Hospital Infection 64 (2), 169-176, 2006 | 127 | 2006 |
| Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study M Yilmaz, N Elaldi, İİ Balkan, F Arslan, AA Batırel, MZ Bakıcı, MG Gozel, ... Annals of clinical microbiology and antimicrobials 15, 1-10, 2016 | 89 | 2016 |
| Comparative activity of carbapenem testing: the COMPACT study P Nordmann, JJ Picazo, R Mutters, V Korten, A Quintana, JM Laeuffer, ... Journal of antimicrobial chemotherapy 66 (5), 1070-1078, 2011 | 82 | 2011 |
| Cerebrospinal Fluid Interleukin-1 β/InterLeukin-1 Receptor Antagonist Balance and Tumor Necrosis Factor-α Concentrations in Tuberculous, Viral and Acute Bacterial Meningitis H Akalin, C Akdiş, R Mistik, S Helvaci, K Kiliçturgay Scandinavian journal of infectious diseases 26 (6), 667-674, 1994 | 80 | 1994 |
| Prognostic risk factors in ventilator-associated pneumonia Z Karakuzu, R Iscimen, H Akalin, NK Girgin, F Kahveci, M Sinirtas Medical science monitor: international medical journal of experimental and …, 2018 | 77 | 2018 |
| Guillain‐Barré syndrome in a patient with minimal symptoms of COVID‐19 infection E Oguz‐Akarsu, R Ozpar, H Mirzayev, NA Acet‐Ozturk, B Hakyemez, ... Muscle & nerve 62 (3), E54-E57, 2020 | 76 | 2020 |
| Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit S Osma, ŞF Kahveci, FN Kaya, H Akalın, C Özakın, E Yılmaz, O Kutlay Journal of Hospital Infection 62 (2), 156-162, 2006 | 76 | 2006 |
| Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected M Ruhnke, JA Paiva, W Meersseman, J Pachl, I Grigoras Clin Microbiol Infect 18 (7), 680-687, 2012 | 74 | 2012 |
| Evaluation of the modified MEDS, MEWS score and Charlson comorbidity index in patients with community acquired sepsis in the emergency department E Çıldır, M Bulut, H Akalın, E Kocabaş, G Ocakoğlu, ŞA Aydın Internal and emergency medicine 8, 255-260, 2013 | 73 | 2013 |
| Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic H Agca, H Akalin, I Saglik, M Hacimustafaoglu, S Celebi, B Ener Journal of Infection and Public Health 14 (9), 1186-1190, 2021 | 72 | 2021 |
